Abnova (Taiwan) Corporation (TPE:4133)
Taiwan · Delayed Price · Currency is TWD 23.70
-0.75 (-3.07%)
Mar 4, 2026, 1:35 PM CST
Abnova (Taiwan) Market Cap
Abnova (Taiwan) has a market cap or net worth of 1.48 billion as of March 3, 2026. Its market cap has decreased by -19.97% in one year.
Market Cap
1.48B
Enterprise Value
1.12B
Revenue
351.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.70
Market Cap Chart
Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.48B, a decrease of -49.11%. That is a compound annual growth rate of -3.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.48B | 7.71% |
| Dec 31, 2025 | 1.37B | -23.44% |
| Dec 31, 2024 | 1.80B | -15.53% |
| Dec 29, 2023 | 2.13B | -14.81% |
| Dec 30, 2022 | 2.49B | -5.40% |
| Dec 30, 2021 | 2.64B | -25.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiRx | 2.10B |
| Chunghwa Chemical Synthesis & Biotech | 2.08B |
| Advagene Biopharma | 1.97B |
| Genomics BioSci & Tech. | 1.81B |
| GenMont Biotech Incorporation | 1.53B |
| NeoCore Technology | 1.53B |
| Great Novel Therapeutics Biotech & Medicals | 1.46B |
| Enimmune | 1.36B |